FibroGen, Inc. (FGEN)

EBITDA Growth

70.76%

TTM · Period ending:

FGEN logo

FGEN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported70.76%
FGEN TTM EBITDA YoY % (-2155.40% → 70.76%)
High-resolution chart · PNG

FGEN ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

FibroGen, Inc. EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
70.7606%
80.5644%
76.7415%
18.1698%
35.6687%
31.3592%
24.5136%
43.0724%
34.5428%
19.2072%
7.4672%
22.0317%
-46.7635%
-9.7698%
-3.6024%
-81.6965%
-0.5566%
-70.5805%
-65.7929%
5.3327%
27.5555%
-75.4792%
-191.4154%
-454.1444%
-558.5138%
-19.8907%
21.9758%
151.1821%
165.1868%
29.3571%
24.6505%
-5.4893%
8.995%
-117.7653%
-106.3053%
-67.0934%
-21.6998%
9.9269%
35.3237%
10.8909%
-33.7018%
28.5131%
-61.108%
-246.2455%
-213.5119%
-9,703.8217%
-2,155.404%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.